Everolimus is approved for various conditions:

-Advanced kidney cancer (US FDA approved in March 2009)
-Prevention of organ rejection after renal transplant(US FDA April 2010)
-Subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS) in patients who are not suitable for surgical intervention (US FDA October 2010)
-Progressive or metastatic pancreatic neuroendocrine tumors not surgically removable (May 2011)
-Breast cancer in post-menopausal women with advanced hormone-receptor positive, HER2-negative type cancer, in conjunction with exemestane (US FDA July 2012)
-Prevention of organ rejection after liver transplant(Feb 2013)
-Progressive, well-differentiated non-functional, neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin with unresectable, locally advanced or metastatic disease (US FDA February 2016).
-Tuberous sclerosis complex-associated partial-onset seizures for adult and pediatric patients aged 2 years and older. (US FDA April 2018).

everolimus is available in India on request-

Lucknow Speciality Pharma is the leading Pharma brand and one of the most leading Pharma Wholesalers in Lucknow. We are expanding our reach across India. To get “AFINITOR (everolimus) Tablets“, patients can simply fill the order form or can send mail at info@lucknowpharma.com. Patients can also send WhatsApp messages to +91-9555306364, The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.